Gilead Files for FDA OK of New All-Genotype Hepatitis C Treatment
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The HepatitisC.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Gilead Files for FDA OK of New All-Genotype Hepatitis C Treatment. (2016). HEP. Retrieved 17 January 2017, from https://www.hepmag.com/article/gilead-files-fda-ok-new-allgenotype-hepatitis-c-treatment
- Seth, S. (2016). Gilead Files New Drug Application for Hep C Combo. Investopedia. Retrieved 17 January 2017, from http://www.investopedia.com/news/gilead-submits-nda-hepatitis-c-combo-gild/
- Taylor, P. (2016). Gilead files hepatitis C salvage regimen in US - PMLiVE. Pmlive.com. Retrieved 17 January 2017, from http://www.pmlive.com/pharma_news/gilead_files_hepatitis_c_salvage_regimen_in_us_1181378